These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34553255)

  • 1. Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary function.
    Schiwek M; Triphan SMF; Biederer J; Weinheimer O; Eichinger M; Vogelmeier CF; Jörres RA; Kauczor HU; Heußel CP; Konietzke P; von Stackelberg O; Risse F; Jobst BJ; Wielpütz MO;
    Eur Radiol; 2022 Mar; 32(3):1879-1890. PubMed ID: 34553255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of quantitative regional perfusion-weighted phase resolved functional lung (PREFUL) MRI with dynamic gadolinium-enhanced regional pulmonary perfusion MRI in COPD patients.
    Kaireit TF; Voskrebenzev A; Gutberlet M; Freise J; Jobst B; Kauczor HU; Welte T; Wacker F; Vogel-Claussen J
    J Magn Reson Imaging; 2019 Apr; 49(4):1122-1132. PubMed ID: 30350440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsupervised clustering algorithms improve the reproducibility of dynamic contrast-enhanced magnetic resonance imaging pulmonary perfusion quantification in muco-obstructive lung diseases.
    Konietzke M; Triphan SMF; Eichinger M; Bossert S; Heller H; Wege S; Eberhardt R; Puderbach MU; Kauczor HU; Heußel G; Heußel CP; Risse F; Wielpütz MO
    Front Med (Lausanne); 2022; 9():1022981. PubMed ID: 36353218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of pulmonary perfusion using dynamic contrast-enhanced CT in patients with chronic obstructive pulmonary disease: correlations with pulmonary function test and CT volumetric parameters.
    Guan Y; Xia Y; Fan L; Liu SY; Yu H; Li B; Zhao LM; Li B
    Acta Radiol; 2015 May; 56(5):573-80. PubMed ID: 24917608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast enhanced magnetic resonance perfusion imaging in high-risk smokers and smoking-related COPD: correlations with pulmonary function tests and quantitative computed tomography.
    Xia Y; Guan Y; Fan L; Liu SY; Yu H; Zhao LM; Li B
    COPD; 2014 Sep; 11(5):510-20. PubMed ID: 25211632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Method for Combined Quantitative Assessment of Air-Trapping and Emphysema on Chest Computed Tomography in Chronic Obstructive Pulmonary Disease: Comparison with Parametric Response Mapping.
    Hwang HJ; Seo JB; Lee SM; Kim N; Yi J; Lee JS; Lee SW; Oh YM; Lee SD
    Korean J Radiol; 2021 Oct; 22(10):1719-1729. PubMed ID: 34269529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-series hyperpolarized xenon-129 MRI of lobar lung ventilation of COPD in comparison to V/Q-SPECT/CT and CT.
    Doganay O; Matin T; Chen M; Kim M; McIntyre A; McGowan DR; Bradley KM; Povey T; Gleeson FV
    Eur Radiol; 2019 Aug; 29(8):4058-4067. PubMed ID: 30552482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic features of pulmonary function test, CT volume analysis and MR perfusion imaging in COPD patients with different HRCT phenotypes.
    Fan L; Xia Y; Guan Y; Zhang TF; Liu SY
    Clin Respir J; 2014 Jan; 8(1):45-54. PubMed ID: 23711228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtyping preserved ratio impaired spirometry (PRISm) by using quantitative HRCT imaging characteristics.
    Lu J; Ge H; Qi L; Zhang S; Yang Y; Huang X; Li M
    Respir Res; 2022 Nov; 23(1):309. PubMed ID: 36369019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Automated Perfusion-Weighted Phase-Resolved Functional Lung (PREFUL)-MRI in Patients With Pulmonary Diseases.
    Behrendt L; Voskrebenzev A; Klimeš F; Gutberlet M; Winther HB; Kaireit TF; Alsady TM; Pöhler GH; Derlin T; Wacker F; Vogel-Claussen J
    J Magn Reson Imaging; 2020 Jul; 52(1):103-114. PubMed ID: 31872556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echo time-dependent observed T1 and quantitative perfusion in chronic obstructive pulmonary disease using magnetic resonance imaging.
    Triphan SMF; Konietzke M; Biederer J; Eichinger M; Vogelmeier CF; Jörres RA; Kauczor HU; Heußel CP; Jobst BJ; Wielpütz MO;
    Front Med (Lausanne); 2023; 10():1254003. PubMed ID: 38249975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of machine learning model to predict pulmonary function with low-dose CT-derived parameter response mapping in a community-based chest screening cohort.
    Zhou X; Pu Y; Zhang D; Guan Y; Lu Y; Zhang W; Fu CC; Fang Q; Zhang H; Liu S; Fan L
    J Appl Clin Med Phys; 2023 Nov; 24(11):e14171. PubMed ID: 37782241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative CT detects progression in COPD patients with severe emphysema in a 3-month interval.
    Konietzke P; Wielpütz MO; Wagner WL; Wuennemann F; Kauczor HU; Heussel CP; Eichinger M; Eberhardt R; Gompelmann D; Weinheimer O
    Eur Radiol; 2020 May; 30(5):2502-2512. PubMed ID: 31965260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GOLD-Grade Specific Disease Characterization and Phenotyping of COPD Using Quantitative Computed Tomography in the Nationwide COSYCONET Multicenter Trial in Germany.
    Konietzke P; Weinheimer O; Triphan SMF; Nauck S; Wuennemann F; Konietzke M; Jobst BJ; Jörres RA; Vogelmeier CF; Heussel CP; Kauczor HU; Biederer J; Wielpütz MO;
    Respiration; 2024 Aug; ():1-17. PubMed ID: 39173593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal inference analysis of the radiologic progression in the chronic obstructive pulmonary disease.
    Im Y; Lee K; Lee SM; Shin SH; Choi Y; Lee JS; Oh YM; Kim J; Oh YJ; Lee HY; Park HY
    Sci Rep; 2024 Aug; 14(1):17838. PubMed ID: 39090153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative CT Analysis in Patients with Pulmonary Emphysema: Do Calculated Differences Between Full Inspiration and Expiration Correlate with Lung Function?
    Song L; Leppig JA; Hubner RH; Lassen-Schmidt BC; Neumann K; Theilig DC; Feldhaus FW; Fahlenkamp UL; Hamm B; Song W; Jin Z; Doellinger F
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1877-1886. PubMed ID: 32801683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitatively assessed dynamic contrast-enhanced magnetic resonance imaging in patients with chronic obstructive pulmonary disease: correlation of perfusion parameters with pulmonary function test and quantitative computed tomography.
    Jang YM; Oh YM; Seo JB; Kim N; Chae EJ; Lee YK; Lee SD
    Invest Radiol; 2008 Jun; 43(6):403-10. PubMed ID: 18496045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS).
    Boes JL; Hoff BA; Bule M; Johnson TD; Rehemtulla A; Chamberlain R; Hoffman EA; Kazerooni EA; Martinez FJ; Han MK; Ross BD; Galbán CJ
    Acad Radiol; 2015 Feb; 22(2):186-94. PubMed ID: 25442794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Novel Computed Tomography Analysis to Describe the Contribution and Distribution of Emphysema and Small Airways Disease in Chronic Obstructive Pulmonary Disease.
    Ostridge K; Gove K; Paas KHW; Burke H; Freeman A; Harden S; Kirby M; Peterson S; Sieren J; McCrae C; Vaarala O; Staples KJ; Wilkinson TMA
    Ann Am Thorac Soc; 2019 Aug; 16(8):990-997. PubMed ID: 30892055
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease.
    Nambu A; Zach J; Schroeder J; Jin G; Kim SS; Kim YI; Schnell C; Bowler R; Lynch DA
    Eur J Radiol; 2016 Nov; 85(11):2144-2151. PubMed ID: 27776670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.